Reference health
Solubility Behavior of Boc-L-proline in 14 Pure Solvents from 283.15 to 323.15 K
52/52 checkable references clean · checked 2026-07-26
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 52 checked references that resolve
resolves10.1016/j.jhep.2006.05.013
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
resolves10.1056/NEJMoa1306218
Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
resolves10.1111/j.1365-2893.2006.00785.x
Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States
resolves10.1053/j.gastro.2010.12.032
Increasing Prevalence of HCC and Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
resolves10.1111/j.1478-3231.2011.02539.x
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
resolves10.1111/j.1478-3231.2011.02540.x
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
resolves10.1111/apt.13081
Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection
resolves10.1007/s12072-015-9668-3
Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection
resolves10.1128/AAC.00054-12
Genotype and Subtype Profiling of PSI-7977 as a Nucleotide Inhibitor of Hepatitis C Virus
resolves10.1002/hep.24609
Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1
resolves10.1016/S1473-3099(12)70138-X
Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial
resolves10.1039/C6OB00340K
An atom-efficient and convergent approach to the preparation of NS5A inhibitors by C–H activation
resolves10.1016/j.tetasy.2004.01.005
Boc-l-proline as a new chiral ligand for enantioselective phenylacetylene addition to aromatic aldehydes
resolves10.1021/acs.oprd.8b00190
Improved Understanding of Cefixime Trihydrate Reactive Crystallization and Process Scale-up with the Aid of PAT
resolves10.1021/acs.jced.0c00513
Measurement and Correlation of Solubility and Thermodynamic Properties of Fluoxetine Hydrochloride in 15 Pure Solvents and a Methanol + Water Binary Solvent System
resolves10.1021/acs.jced.8b00361
Determination and Correlation of the Solubility of <scp>l</scp>-Fucose in Four Binary Solvent Systems at the Temperature Range from 288.15 to 308.15 K
resolves10.1021/acs.jced.9b00802
Solubility Behavior and Data Modeling of <scp>l</scp>-Proline in Different Neat and Binary Solvent Systems
resolves10.1021/acs.jced.0c00794
Measurement and Correlation of <i>trans</i>-4-Hydroxy-<scp>l</scp>-proline Solubility in Sixteen Individual Solvents and a Water + Acetonitrile Binary Solvent System
resolves10.1021/acs.jced.9b00743
Measurement and Correlation for Solubility of <scp>l</scp>-Alanine in Pure and Binary Solvents at Temperatures from 283.15 to 323.15 K
resolves10.1021/acs.jced.0c00009
Determination and Correlation of <scp>d</scp>-Ribose Solubility in Twelve Pure and Four Binary Solvent Systems
resolves10.1021/acs.jced.0c00015
Measurement and Correlation for Solubility of Moroxydine Hydrochloride in Pure and Binary Solvents
resolves10.1021/acs.jced.9b00029
Determination and Correlation of the Solubility of Sodium Naphthalene-1,5-disulfonate in Five Pure Solvents and Three Binary Solvent Systems at the Temperature Range from 283.15 to 323.15 K
resolves10.1021/acs.jced.9b01203
Determination and Correlation of the Solubility of Monosodium Fumarate in Different Neat and Binary Solvent Systems
resolves10.1021/acs.jced.0c00031
Determination and Correlation of the Solubility of <scp>l</scp>-Cysteine in Several Pure and Binary Solvent Systems
resolves10.1006/jcht.1997.0267
Solubilities ofL-aspartic,DL-aspartic,DL-glutamic, -hydroxybenzoic, -anisic, -anisic, and itaconic acids in water from =278 K to =345 K
resolves10.1006/jcht.1998.0424
Solubilities ofo-acetylsalicylic, 4-aminosalicylic, 3,5-dinitrosalicylic, andp-toluic acid, and magnesium- -aspartate in water fromT=(278 to 348) K
resolves10.1016/j.jct.2015.09.032
Correlation and thermodynamic analysis of solubility of diphenhydramine hydrochloride in pure and binary solvents
resolves10.1021/acs.jced.0c01032
Solubility Measurement and Data Correlation of 2,3-Dihydroxybenzoic Acid in 12 Monosolvents at Temperatures from 278.15 to 318.15 K
resolves10.1016/j.fluid.2004.08.040
Solubility measurement and modeling for the system propane–water from 277.62 to 368.16 K
resolves10.1016/j.fluid.2017.12.035
Solubility of 1,1-diamino-2,2-dinitroethylene in different pure solvents and binary mixtures (dimethyl sulfoxide + water) and (N,N-dimethylformamide + water) at different temperatures
resolves10.1021/acs.jced.9b01192
Solubility of Octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine in 12 Pure Organic Solvents from 298.15 to 358.15 K
resolves10.1021/acs.jced.0c00776
Multicomponent Solid–Liquid Equilibrium of 1,3,5-Triformylbenzene—A Key Intermediate for Porous Organic Cages: Solubility Determination and Correlation in Different Solvent Systems
resolves10.1016/j.jct.2015.08.035
Thermodynamic equilibrium of 4-hydroxy-2,5-dimethyl-3(2H)-furanone in different solvent systems
resolves10.1016/j.jct.2016.06.032
Determination and correlation of solubility of 4′-bromomethyl-2-cyanobiphenyl in acetone + (ethanol, n-propanol, n-butanol) mixtures
resolves10.1021/acs.jced.9b00229
Solubility Determination and Model Correlation of Pymetrozine and Evaluation of the Effect of Solvent Properties and Composition
resolves10.1039/cs9932200409
The properties of organic liquids that are relevant to their use as solvating solvents
resolves10.1016/j.ijpharm.2004.06.021
Grouping solvents by statistical analysis of solvent property parameters: implication to polymorph screening
resolves10.1016/j.molliq.2017.06.037
Solubility and dissolution thermodynamic properties of lansoprazole in pure solvents
resolves10.1021/acs.jced.9b01020
Solubility Measurement and Data Correlation of 5,5-Dimethylhydantoin in 12 Pure Solvents at Temperatures from 283.15 to 323.15 K
resolves10.1021/acs.jced.6b00630
Solubility Correlation and Thermodynamic Analysis of Sorafenib Free Base and Sorafenib Tosylate in Monosolvents and Binary Solvent Mixtures
resolves10.1021/acs.jced.9b00428
Solubility Determination and Modeling of EGCG Peracetate in 12 Pure Solvents at Temperatures from 278.15 to 318.15 K
resolves10.1021/acs.jced.9b01164
Solubility Measurement and Data Correlation of Isatoic Anhydride in 12 Pure Solvents at Temperatures from 288.15 to 328.15 K
resolves10.1021/acs.jced.0c00724
Solubility Measurement and Data Correlation of Thiabendazole in 12 Pure Organic Solvents from 283.15 to 323.15 K
resolves10.1002/jps.2600750702
Intrinsic Molecular Volume as a Measure of the Cavity Term in Linear Solvation Energy Relationships: Octanol-Water Partition Coefficients and Aqueous Solubilities
resolves10.1016/0925-4005(91)80202-U
Solubility interactions and the design of chemically selective sorbent coatings for chemical sensors and arrays
resolves10.1016/j.molliq.2019.02.023
Solubility measurement, correlation and mixing thermodynamics properties of dapsone in twelve mono solvents
resolves10.1021/acs.jced.9b01036
Solubility Determination, Model Correlation, and Solvent Effect Analysis of Nisoldipine in Different Solvent Systems at a Series of Temperature
The 3 references without a DOI — listed, not checked
no DOI — not checkedCrystallization
no DOI — not checkedHandbook of Organic Solvent Properties
no DOI — not checkedComputational Studies, Nanotechnology, and Solution Thermodynamics of Polymer Systems
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-26 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1021/acs.jced.1c00201"><img src="https://citestamp.com/citestamped/10.1021/acs.jced.1c00201/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1021/acs.jced.1c00201)